NCT06985875View on ClinicalTrials.gov

Clinical Trial for the Evaluation of Safety and Efficacy of Drop 0.4%

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Eye Dryness
Interventions
DEVICE

Multidose mosturizing solution DROP 0.4%

Ophthalmic mosturizing solution to be administered 1-4 times per day in both eyes

DEVICE

Multidose mosturizing solution Avizor Eye Drops 0.2% Preserved

Ophthalmic mosturizing solution to be administered 1-4 times per day in both eyes

All Listed Sponsors
collaborator

Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA

OTHER

lead

Avizor SA

INDUSTRY

NCT06985875 - Clinical Trial for the Evaluation of Safety and Efficacy of Drop 0.4% | Biotech Hunter | Biotech Hunter